Fda Approves New Cholesterol Drug, Repatha

Repatha is part of a new class of drugs known as PCSK9 inhibitors, or antibodies which work on the liver to lower cholesterol.

Topics:  pcsk9   cholesterol   drug   repatha   
BING NEWS:
  • New research underway on monthly shot to treat high cholesterol
    A new therapy could help a person lower his or her risk of having a heart attack. New research is explaining how.
    04/15/2024 - 6:47 am | View Link
  • Clinical trials getting underway on cholesterol treatments
    Local researchers are testing some newer therapies, which could help reduce a person's risk of a heart attack.
    04/15/2024 - 5:55 am | View Link
  • U.S. FDA approves Akebia's anemia drug
    opens new tab drug, vadadustat, to treat anemia caused by chronic kidney disease (CKD) in dialysis patients, the drugmaker said on Wednesday. The drug will be available under the brand name Vafseo ...
    03/28/2024 - 3:17 am | View Link
  • FDA approves Akebia anemia pill, two years after rejection
    The Food and Drug Administration has approved Akebia Therapeutics’ blood-boosting pill Vafseo for people with anemia from chronic kidney disease, the company said Wednesday, reversing a ...
    03/28/2024 - 1:03 am | View Link
  • FDA approves new drug that may help stop a rare, fatal condition that doctors call a ‘ticking time bomb’
    Then her medical team offered her a potential lifeline: a first-of-its-kind experimental drug called sotatercept that corrals a growth factor that is overproduced by people with PAH, potentially ...
    03/25/2024 - 1:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News